CClinicalTrials.gg
Sign In
Status unknownNCT05146947Updated Dec 7, 2021

Intraoperative Near Infrared Spectroscopy of Kidney for Prediction of Acute and Sub-acute Kidney Injury in Partial Nephrectomy

An interventional study of near infrared spectroscopy in Kidney Injury, sponsored by Tel-Aviv Sourasky Medical Center. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-12-07.

Sponsored by Tel-Aviv Sourasky Medical Center · Not applicable, Interventional, and Screening

The sponsor has not verified this record recently (last verified Dec 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Intra-operative NIRS measurements of kidney during partial nephrectomy, after reperfusion, for monitoring ischemia and prediction of postoperative renal dysfunction.

02

Conditions studied

  • Kidney Injury
03

In context

Acute Kidney Injury

1,595 studies on the registry are indexed under Acute Kidney Injury; 371 are open to participants now.

This study's planned enrollment of 90 is close to the median of 100 across 763 interventional studies indexed under Acute Kidney Injury.

Browse Acute Kidney Injury studies →

Lead sponsor

Tel-Aviv Sourasky Medical Center is the lead sponsor of 541 studies on the registry; 49 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Candidates for partial nephrectomy at Tel Aviv Medical Center who will consent to participate.

Exclusion criteria

Exclusion Criteria:

  • Patients unable to give consent,
  • Patients who were lost to follow up during the first 7 post-operative days.
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
90 participants (estimated)

Interventions

  • Devicenear infrared spectroscopy

    near infrared spectroscopy monitoring on kidney after reperfusion

06

What researchers measure

Primary outcomes

  1. Acute Kidney Injury

    An increase in serum creatinine by 0.3mg/dL or more within 48 hours compared with admission creatinine level or an increase in serum creatinine above 1.5 times baseline within 7 days of admission

    Time frame: 7 days post operative and during 6 months post-surgery.

Secondary outcomes

  1. Surgical complications

    Vascular/Bleeding ect.

    Time frame: 7 days post operative

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 7, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05146947
Lead sponsor
Tel-Aviv Sourasky Medical Center
Responsible party
Sponsor
First posted
Dec 7, 2021
Start date
Dec 1, 2021 (estimated)
Primary completion
Dec 31, 2023 (estimated)
Completion
Feb 28, 2024 (estimated)
Last update
Dec 7, 2021

Study contacts

Orr Goren, Dr
Contact
org@tlvmc.gov.il
+972527360972
Orr Goren, Dr
principal investigator · Tel Aviv Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Acute Kidney Injury→

Other studies from this sponsor

Tel-Aviv Sourasky Medical Center

Start the discussion